FDA Adverse Event Injury Summary report: N

OMNI SURGICAL SYSTEM

MDR report key: 9466903 · Received December 13, 2019

Report

Report Number
3010363671-2019-00002
Event Type
Injury
Date Received
December 13, 2019
Date of Event
October 17, 2019
Report Date
December 13, 2019
Manufacturer
SIGHT SCIENCES, INC.
Product Code
MRH
UDI-DI
00858027006310
PMA / PMN Number
K173332
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ALL PERTINENT INFORMATION AVAILABLE TO SIGHT SCIENCES, INC. HAS BEEN SUBMITTED. THE COMPANY IS SUBMITTING THIS MDR TO ENSURE FULL COMPLIANCE WITH 21 CFR PART 803. MFR REFERENCE #: (B)(4).

Description of Event or Problem · 1

ON (B)(6) 2019, THE SURGEON PERFORMED VISCODILATION AND GONIOTOMY WITH THE OMNI SURGICAL SYSTEM AS WELL AS CATARACT SURGERY. SURGERY WAS UNEVENTFUL AND THERE WERE NO INTRAOPERATIVE COMPLICATIONS. AT ONE WEEK POST-SURGERY, THE PATIENT HAD HYPOTONY WITHOUT ANY CLINICAL SIGNS AND THE VISUAL ACUITY WAS UNCHANGED FROM PRE-OP (20/50). THE PATIENT WAS PRESCRIBED STEROIDS TO INCREASE THE IOP. THE PATIENT'S PRESSURE CONTINUED TO BE LOW FOR THE FIRST MONTH POST-SURGERY. AT APPROXIMATELY 6 WEEKS POST-SURGERY ((B)(6) 2019), THE IOP INCREASED TO 10 MMHG BUT THE VISUAL ACUITY HAD DECREASED TO 20/400. AT APPROXIMATELY 2 MONTHS POST-SURGERY ((B)(6) 2019), WITH THE PRESSURE STILL LOW AND THE VISION AT 20/200, THE PATIENT WAS SEEN BY A NEURO-OPHTHALMOLOGIST WHO DIAGNOSED THE PATIENT WITH PAPILLEDEMA DUE TO AN EXTENDED PERIOD OF LOW PERFUSION AS A RESULT OF LOW IOP. THE PATIENT IS UNDER TREATMENT AND OBSERVATION. THE OPTIC NERVE SWELLING HAS REDUCED BUT THE VISION IS STILL 20/200. THE DOCTOR IS UNABLE TO DETERMINE THE PATHOPHYSIOLOGY BEHIND THE PAPILLEDEMA.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1259100 OMNI SURGICAL SYSTEM VISCOELASTIC INJECTOR MRH SIGHT SCIENCES, INC. 05600 00858027006310

Patients

Seq Age Sex Outcome Treatment
1 62 YR Other